5.06
price down icon11.54%   -0.66
 
loading

Ardelyx Inc (ARDX) 最新ニュース

pulisher
02:07 AM

Ardelyx CEO Michael Raab sells $129,124 in company stock By Investing.com - Investing.com Australia

02:07 AM
pulisher
Feb 21, 2025

Ardelyx CFO Justin Renz sells $29,076 in stock By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx (ARDX) Earnings Call: Strong Growth Amidst Challenges - TipRanks

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx chief legal officer sells $24,128 in stock By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx chief medical officer Laura Williams sells $27,783 in stock - Investing.com India

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx chief medical officer Laura Williams sells $27,783 in stock By Investing.com - Investing.com Australia

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx CEO Michael Raab sells $129,124 in company stock - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx CFO Justin Renz sells $29,076 in stock - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx Executives Sell Shares to Cover Tax Obligations - TradingView

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx chief legal officer sells $24,128 in stock - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx, Inc. (NASDAQ:ARDX) Q4 2024 Earnings Call Transcript - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

H.C. Wainwright holds Ardelyx stock at $5.50 target, neutral stance By Investing.com - Investing.com Australia

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx (NASDAQ:ARDX) Releases Earnings Results, Hits Estimates - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx price target lowered to $13 from $15 at Raymond James - TipRanks

Feb 21, 2025
pulisher
Feb 21, 2025

H.C. Wainwright holds Ardelyx stock at $5.50 target, neutral stance - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Breaking Down Ardelyx: 4 Analysts Share Their Views - Benzinga

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx Stock Rises After-Hours On Q4 Beat, Drug Sales Outlook: Retail Gets Big Dose Of Optimism - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx Inc. Grapples with Trade Secret Risks Threatening Financial Stability - TipRanks

Feb 21, 2025
pulisher
Feb 20, 2025

Ardelyx Reports Strong 2024 Financial Performance - TipRanks

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx: Q4 Earnings Snapshot - mySA

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

ARDELYX, INC. SEC 10-K Report - TradingView

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx (ARDX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance

Feb 20, 2025
pulisher
Feb 20, 2025

Earnings call transcript: Ardelyx beats Q4 2024 forecasts, stock dips - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx Inc earnings beat by $0.01, revenue topped estimates - Investing.com Nigeria

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx (ARDX) Meets Q4 Earnings Estimates - Yahoo Finance

Feb 20, 2025
pulisher
Feb 20, 2025

Earnings Flash (ARDX) Ardelyx Posts Q4 EPS $0.02, vs. FactSet Est of $0.03 -February 20, 2025 at 07:54 am EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Feb 20, 2025
pulisher
Feb 20, 2025

Can Ardelyx's $334M Revenue and Dual Blockbuster Strategy Transform Biotech Investment? - StockTitan

Feb 20, 2025
pulisher
Feb 19, 2025

Shareholders of Ardelyx, Inc. Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire

Feb 19, 2025
pulisher
Feb 19, 2025

Ardelyx (NASDAQ:ARDX) Trading Up 7.9%Here's Why - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference - The Manila Times

Feb 19, 2025
pulisher
Feb 19, 2025

Can Ardelyx's Presentation at TD Cowen Conference Reveal New Growth Catalysts? - StockTitan

Feb 19, 2025
pulisher
Feb 18, 2025

Ardelyx, Inc. (NASDAQ:ARDX) Sees Significant Increase in Short Interest - MarketBeat

Feb 18, 2025
pulisher
Feb 18, 2025

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 18, 2025
pulisher
Feb 18, 2025

Ardelyx (ARDX) to Release Earnings on Thursday - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

Ardelyx director David Mott buys $992,671 in company stock - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

There's No Escaping Ardelyx, Inc.'s (NASDAQ:ARDX) Muted Revenues - Simply Wall St

Feb 17, 2025
pulisher
Feb 16, 2025

Ardelyx spikes as chairman buys nearly $1M worth of stock - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Ardelyx (ARDX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Feb 16, 2025
pulisher
Feb 13, 2025

(ARDX) Technical Data - Stock Traders Daily

Feb 13, 2025
pulisher
Feb 13, 2025

Ardelyx (ARDX) Earnings Expected to Grow: Should You Buy? - Nasdaq

Feb 13, 2025
pulisher
Feb 11, 2025

Ardelyx, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire

Feb 11, 2025
pulisher
Feb 11, 2025

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

Feb 11, 2025
pulisher
Feb 10, 2025

Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Feb 10, 2025
pulisher
Feb 07, 2025

ARDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 07, 2025
pulisher
Feb 05, 2025

State Street Corp Reduces Stake in Ardelyx Inc: Analyzing the Im - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Ardelyx (NASDAQ:ARDX) Upgraded to "Strong-Buy" at Cantor Fitzgerald - MarketBeat

Feb 05, 2025
pulisher
Feb 05, 2025

Ardelyx, Inc. (NASDAQ:ARDX) CEO Michael Raab Sells 41,666 Shares - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx, Inc. LawsuitARDX - ACCESS Newswire

Feb 04, 2025
pulisher
Feb 04, 2025

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com

Feb 04, 2025
pulisher
Feb 03, 2025

Analysts Set Ardelyx, Inc. (NASDAQ:ARDX) PT at $9.42 - MarketBeat

Feb 03, 2025
pulisher
Jan 31, 2025

Ardelyx (NASDAQ:ARDX) Given New $8.00 Price Target at Piper Sandler - MarketBeat

Jan 31, 2025
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):